In the present study, IL-6 levels in the initial blood samples obtained from patients with septic shock significantly decreased in the recovery group but increased among the death group, which suggests that IL-6 levels can be used to monitor the effectiveness of treatment for septic shock. The gene discussed is IL6; the disease is septic shock.